Partial A1 Adenosine Receptor Agonists from a Molecular Perspective and Their Potential Use as Chronic Ventricular Rate Control Agents During Atrial Fibrillation (AF)

Publisher： Bentham Science Publishers

E-ISSN： 1873-4294|4|8|839-854

ISSN： 1568-0266

Source： Current Topics in Medicinal Chemistry, Vol.4, Iss.8, 2004-04, pp. : 839-854

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The use of digoxin for atrial fibrillation (AF) treatment has decreased over time in the US, but "without a concomitant increase in the use of other agents for rate control"

By  

Inpharma, Vol. 1, Iss. 1425, 2004-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

A1 adenosine receptor agonists and their potential therapeutic applications

By Elzein Elfatih   Zablocki Jeff  

Expert Opinion on Investigational Drugs, Vol. 17, Iss. 12, 2008-12 ,pp. : 1901-1910

Informa Healthcare

Access to resources Recommend Favorite

Dronedarone improves ventricular rate control among patients with atrial fibrillation

By  

Inpharma, Vol. 1, Iss. 1660, 2008-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

A1 Adenosine Receptor Agonists: Medicinal Chemistry and Therapeutic Potential

By  

Current Pharmaceutical Design, Vol. 10, Iss. 17, 2004-01 ,pp. : 2021-2039

Bentham Science Publishers

Access to resources Recommend Favorite

Atrial Fibrillation: Rhythm or Rate Control?

By  

Heart Drug, Vol. 3, Iss. 3, 2003-11 ,pp. : 164-170

Karger

Access to resources Recommend Favorite